"Similar to MDA Space, SatixFy is an innovation company at its core, and bringing these two highly skilled teams together ...

The company’s backlog as of the end of the fourth quarter grew to C$4.39 billion, up from C$3.1 billion a year earlier. MDA’s new contracts include advanced phases for the Canadarm3 for the ...

MDA Space faces aerospace pressures but expects strong growth in 2025. Read why MDA:CA stock could reach $22.57, driven by new product lines and expertise.

Under the purchase order, SatixFy will provide engineering models and space-grade chips, which will be used for internal testing and assembly in MDA Space's satellites. These advanced chips and ...

On an adjusted basis, MDA says it earned 28 cents per diluted share in its latest quarter, up from an adjusted profit of 23 cents per diluted share a year earlier. The company’s backlog stood at ...

--(BUSINESS WIRE)--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company ... the Muscular Dystrophy Association (MDA) Clinical and Scientific Conference.

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company with development efforts focused on rare diseases, today announced that results from its Phase 2 FIGHT DMD clinical ...

MDA Space MDA-0.69%decrease ... Chief Executive Mike Greenley said 90% of the Canadian aerospace company’s 4.39 billion Canadian dollar (US$3.07 billion) backlog is outside of the U.S., and ...